Soligenix Announced That Analysis Of The Post-treatment Data From The Open-label Study Comparing HyBryte (Synthetic Hypericin) To Valchlor (Mechlorethamine) Has Demonstrated Continued Improvement In HyBryte-treated Patients And Their Individual...
Soligenix Announced That Analysis Of The Post-treatment Data From The Open-label Study Comparing HyBryte (Synthetic Hypericin) To Valchlor (Mechlorethamine) Has Demonstrated Continued Improvement In HyBryte-treated Patients And Their Individual...
soligenix公告称，针对开放标签研究中比较HyBryte（合成高紫色色素）与Valchlor（美克氯胺）的治疗后数据的分析显示，接受HyBryte治疗的患者及其个体......的持续改善。
Soligenix Announced That Analysis Of The Post-treatment Data From The Open-label Study Comparing HyBryte (Synthetic Hypericin) To Valchlor (Mechlorethamine) Has Demonstrated Continued Improvement In HyBryte-treated Patients And Their Individual Lesions Even After Stopping Treatment
soligenix公告称，针对开放标签研究中比较HyBryte（合成高紫色色素）与Valchlor（美克氯胺）的治疗后数据的分析显示，即使在停止治疗后，接受HyBryte治疗的患者及其个体病变仍持续改善。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。